RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

Core Insights - RxSight, Inc. has appointed Raymond W. Cohen to its Board of Directors, which is expected to enhance the company's growth strategy and market reach in the ophthalmic medical device sector [1][2]. Company Overview - RxSight, Inc. specializes in ophthalmic medical devices, focusing on providing customized vision solutions for patients post-cataract surgery [4]. - The company's flagship product, the RxSight® Light Adjustable Lens system, is the first commercially available intraocular lens technology that can be adjusted after surgery, allowing for tailored vision outcomes [4]. Leadership Experience - Raymond W. Cohen brings over 40 years of experience in the medical technology industry, having co-founded Axonics, Inc., which achieved over $1 billion in revenue within four years of its launch and was acquired by Boston Scientific for $3.7 billion in 2024 [2][3]. - Cohen has held various leadership roles in multiple healthcare companies, indicating a strong background in scaling medical technology businesses [3]. Strategic Vision - Cohen sees significant potential for RxSight to strengthen its position in the premium intraocular lens market and aims to support the company's growth in revenue and profits [3]. - The company aims to expand the reach of its Light Adjustable Lens system, thereby benefiting more physicians and patients [2][3].